From Adani Enterprises, Maruti Suzuki, Coal India to Dabur India – Here are 10 stocks to watch Stocks to watch today, August 01: GIFT Nifty indicates a lower start for domestic indices. Here are the top stocks… 1 month ago
Trump tariff impact on Pharma: Breathing easy or trapped in crosshair ahead? Here’s how stocks are reacting Trump’s new tariffs spark uncertainty for India’s pharma exports and stocks; check out how the sector is reacting and what… 1 month agoJuly 31, 2025
Stocks making the biggest moves midday: HCL Tech, HUL, Vedanta, Phoenix Mills and more Track midday stock movers like HCL Tech, Tata Steel, Mankind Pharma, and Vedanta; review key market catalysts and analyst insights… 2 months ago
Mankind to sell its diabetes drug, Empagliflozin, for Rs 5, company expects 50% volume growth: Rajeev Juneja On Wednesday, Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin… 6 months ago
Boehringer Ingelheim’s blockbuster diabetes drug goes off patent today—Will it lower treatment costs in India? Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure. 6 months ago
Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore The integration of BSV is on track, with focus on mandate brands, improving productivity and adopting best practices to ensure… 8 months ago
Q2FY25: Mankind Pharma’s profit jumps 29 percent to Rs 658.88 crore; Revenue up 13.6% to Rs 3,076.51 crore During the quarter, we have launched 1 new product in US taking the total launched products to 42. 10 months ago
Mankind Pharma acquires BSV to expand its portfolio in women’s health and fertility drug market According to the company’s statement, Mankind Pharma may consider to retire, a portion of the debt through a potential equity… 11 months ago
Mankind Pharma transfers OTC Business to subsidiary Mankind Consumer Products Private Limited Mankind Pharma’s consumer products portfolio includes several trusted brands Manforce, HealthOK, Prega News, AcneStar, Unwanted and Gas-O-Fast across categories such… 11 months ago
Meet Juneja Brothers: How they built Rs 95,876 crore Mankind Pharma, India’s fourth largest pharma company Mankind Pharma was founded in 1995 by Ramesh Juneja and his younger brother Rajeev Juneja, marking the beginning of a… 1 year agoSeptember 9, 2024
Mankind Pharma announces entry into topical analgesic market, launches Nimulid Strong Nimulid Strong will be available in both gel and spray variants, offering consumers flexibility in application, the company stated. 1 year ago
Mankind Pharma Q1 Results: Profit rises by 10.2% to Rs 536.49 crore, revenue at Rs 2,893.42 crore Mankind Pharma recorded revenue from operations at Rs 2,893.42 crore, up 12.2 per cent as against Rs 2,578.62 crore during… 1 year ago
Mankind Pharma to acquire 100 percent stake in BSV; Plans to expand high entry barrier portfolio BSV reported revenues of INR 1,723 crore in FY24, delivering robust 20% y-o-y growth with adjusted EBITDA Margins of 28%.… 1 year ago
Mankind Pharma to sell its OTC business on slump sale basis Some of the key OTC products by Mankind Pharma include the anti-inflammatory and anti-bacterial product AcneStar, the HealthOk multivitamin tablets,… 1 year ago
ChrysCapital pares 2.9 per cent stake in Mankind Pharma for Rs 2,469 crore According to the bulk deal data available on the NSE, Beige Ltd offloaded more than 1.16 crore shares, amounting to… 1 year agoMarch 26, 2024
Mankind Pharma beats Q3 profit estimates on strong demand Mankind Pharma, one of India’s leading condom makers, posted a bigger-than-expected rise in third-quarter profit on Wednesday. 2 years agoJanuary 31, 2024
Diwali Special: Top 10 IPOs that sparkled from last Diwali to this Diwali 56 companies that went public since Diwali 2022, collectively raising a staggering Rs 47,890 crore from the primary market, 2 years agoNovember 10, 2023
Mankind Pharma Q2 profit rises by 19.4% to Rs 501.03 crore, revenue at Rs 2708.10 crore Mankind Pharma posted revenue from operations at Rs 2708.10 crore, 11.6 per cent as against Rs 2425.84 crore during the… 2 years ago
Meet Dhruv Malhotra, the man who bought Mankind Pharma’s Poonam Juneja’s Delhi property: Know about his journey & net worth
